In other words, the classification of women with GDM according to the underlying pathophysiological mechanisms involving dysfunctions in insulin sensitivity and insulin resistance has made considerable progress towards offering individualised treatment and enhances our understanding of potential pregnancy complications and outcomes. The gene discussed is INS; the disease is gestational diabetes.